On Wednesday 21 February, representatives from patients, academics, industries, professionals & regulators (i.a. FEDCAR) will gather and address various aspects of health issues that are at stake with the Brexit.
At a critical time when both the UK Government and the EU are preparing for phase II of the Article 50 negotiations, we would like to invite you to this event which will focus on what needs to urgently be prioritised in the negotiations in order to preserve patient safety and public health. To register your attendance, click here.
This event follows a letter addressed in December to EU Public Health Ministers outlining those issues.
WHERE IN BRUSSELS?
24 rue de l’industrie.
In the UEMS headquarters.
WHEN IN THE AFTERNOON?
From 1.30 to 4.30.
Peter O’Donnel, EU-accredited Brussels-based journalist.
14:00- 14:10: Welcome by MEP approaching Soledad Cabezón Ruiz
14:10-14:20: Intro by Nicola Bedlington, European Patients Forum – presenting the joint statement and the key priorities for patients in the Brexit negotiations
14:20- 14:50: Access to medicines and medical technologies
One rep from industry
EFNA board member
14:50- 15:20 Research and innovation
CRUK presents findings of the Technopolis report, etc, EU-UK value added working together.
1 EU 27 researcher (FEAM vice president? Brian Council, etc) value of collaboration with UK
15:20- 15:50 Reciprocal healthcare for future flows of patients post Brexit and training and mobility of medical professionals
Pascal Garel – HOPE Secretary General
Matt Bolz-Johnson, Healthcare and Research Director, EURORDIS
15:50-16:15 Public Health
EPHA or a Joint Action coordinator on value of collaboration from UK in public health activities
16:15-16:30 response from the Article 50 taskforce rep
FYI – Click here for a NHS perspective (on patient access to medicines and medical technologies).